发明名称 TREATMENT OF CANCER WITH SPECIFIC RXR AGONISTS
摘要 A method of treating cancer is disclosed comprising administering to a patient in need of such treatment a RXR agonist at a level below the RAR activating threshold and at or above the RXR effective dose.
申请公布号 US2016120826(A1) 申请公布日期 2016.05.05
申请号 US201614994025 申请日期 2016.01.12
申请人 IO Therapeutics, Inc. 发明人 Chandraratna Roshantha A.
分类号 A61K31/192;A61K31/337;A61K31/282 主分类号 A61K31/192
代理机构 代理人
主权项 1. A method of treating breast cancer comprising administering to a patient in need of such treatment a retinoid X receptor (RXR) agonist at a dose below the Retinoic Acid Receptor (RAR) activating threshold and at or above the RXR effective dose, the RXR agonist has the chemical structure where R is H, lower alkyl or 1 to 6 carbons, or a pharmaceutically acceptable salt of the compound, and the dose of the RXR agonist is from about 0.01 to about 100 mg/m2/day.
地址 San Juan Capistrano CA US